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ABSTRACT: Synaptotagmin 1 (Syt1) is a Ca2+ sensor for SNARE-
mediated, Ca2+-triggered synaptic vesicle fusion in neurons. It is
composed of luminal, transmembrane, linker, and two Ca2+-binding
(C2) domains. Here we describe expression and purification of full-
length mammalian Syt1 in insect cells along with an extensive
biochemical characterization of the purified protein. The expressed
and purified protein is properly folded and has increased α-helical
content compared to the C2AB fragment alone. Post-translational
modifications of Syt1 were analyzed by mass spectrometry, revealing the
same modifications of Syt1 that were previously described for Syt1
purified from brain extract or mammalian cell lines, along with a novel
modification of Syt1, tyrosine nitration. A lipid binding screen with both
full-length Syt1 and the C2AB fragments of Syt1 and Syt3 isoforms revealed new Syt1−lipid interactions. These results suggest a
conserved lipid binding mechanism in which Ca2+-independent interactions are mediated via a lysine rich region of the C2B
domain while Ca2+-dependent interactions are mediated via the Ca2+-binding loops.
T
he Ca2+-triggered fusion of docked synaptic and secretory
vesicles with the plasma membrane causes temporal
release of neurotransmitter and hormone release, respectively.
Members of the SNARE family (soluble N-ethylmaleimide
sensitive factor attachment protein receptor) and accessory
proteins juxtapose vesicles and target membranes and, along
with Ca2+ sensor synaptotagmin and other factors, catalyze
fusion. Synaptotagmins, a family of ∼16 isoforms, consist of a
short N-terminal lumenal (or extracellular) domain, a single
transmembrane α-helix, an unstructured linker, and two C2
Ca2+-binding domains, termed C2A and C2B. Depending on
the isoform, they are localized to synaptic/secretory vesicles or
the plasma membrane. Synaptotagmin 1 (Syt1) acts as a
primary Ca2+ sensor for fast synchronous synaptic vesicle
release and insulin secretion. Synaptotagmins constitute a
highly evolutionarily conserved protein family, especially for
their Ca2+-binding domains. Although some biochemical
studies of Syt1 have been conducted on brain extract or
mammalian cell line immunoprecipitated protein, the bulk of
biochemical characterization, which requires larger amounts of
Syt1, has been conducted on the Escherichia coli-expressed
C2AB fragment of Syt1 consisting of only C2A and C2B
domains. Clearly, Syt1 expressed in E. coli lacks post-
translational modifications, which have been reported in the
mammalian-derived Syt1 studies.
Syt1 is N-glycosylated
1 at Asn24
2 and O-glycosylated at
Thr15 and Thr16
3 in the luminal domain. In the COS-7
mammalian cell line, O-glycosylation has been reported to
occur only in the presence of synaptobrevin.
3 In PC12 cells,
both N- and O-glycosylations contribute to the proper targeting
of Syt1 to secretory vesicles and Syt1 endocytosis.
2,4 In addition
to glycosylation, all five cysteines (Cys74, Cys75, Cys77, Cys79,
and Cys82) in the Syt1 transmembrane proximal region are
stably palmitoylated in PC12 and CV1 cells.
5,6 Palmitoylation
appears to be required for complete N-glycosylation of Syt1.
6
Apart from Syt12, all Syt isoforms have at least one
transmembrane proximal cysteine residue.
Syt1 can be phosphorylated at Thr125 and Thr128 by casein
kinase II
7,8 (Thr128 of Syt1 in Rattus norvegicus corresponds to
Thr129 of Syt1 in Bos taurus identified in ref 8) and at Thr112
by Ca2+/calmodulin-dependent protein kinase II and protein
kinase C
7 as shown in vitro. In vivo, K+-evoked depolarization
or treatment with phorbol ester in rat brain synaptosomes and
PC12 cells induces an increase in the level of phosphorylation
at Thr112.
7
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chemical properties of insect cell-expressed full-length
mammalian Syt1. In addition, we compare the biochemical
properties of insect cell-expressed full-length mammalian Syt1
to those of the still widely used, prokaryotically expressed, Syt1-
C2AB fragment. Using mass spectrometry, we have performed
the first comprehensive analysis of several post-translational
modifications of Syt1. Our results show that insect cell-
expressed Syt1 carries some of the previously described post-
translational modifications (glycosylation and phosphorylation)
along with several new phosphorylation and O-glycosylation
sites. Moreover, we have identified a novel post-translational
modification of Syt1, tyrosine nitration. Furthermore, we have
screened for lipid binding partners of Syt1 and Syt3 using a new
large set of lipids. In addition to previously reported
interactions with anionic lipids, phosphatidylserine (PS),
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2],
9−14
and phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)-
P3],
11 Syt1 also interacts with additional phosphorylated
phosphatidylinositides and other anionic lipids. Furthermore,
Syt1 interacts with different phosphorylated phosphatidylinosi-
tides in a similar fashion, where the lysine rich region on the
C2B domain (with minor contributions from Arg398 and
Arg399) mediates Ca2+-independent interactions and the C2A,
C2B Ca2+-binding loops mediate Ca2+-dependent interactions.
■ EXPERIMENTAL PROCEDURES
Protein Expression. Full-length rat synaptotagmin 1 (1−
421) and full-length Syt1 Gln154Cys, Cys74Ser, Cys75Ser,
Cys77Ser, Cys79Ser, Cys82Ser, Cys277Ser coding sequences
were cloned into the pvl1393 vector (Pharmingen). For affinity
purification, a 3C protease cleavable His10 tag and a 1D4 tag
were added at the C-terminus. Spodoptera frugiperda (Sf9) cells
(Invitrogen) were transfected with pvl1393 carrying the Syt1
gene and linearized AcNPV DNA (Sapphire Baculovirus DNA,
Orbigen) using Cellfectin (Invitrogen). Baculovirus was
amplified in Sf9 cells in 10% fetal bovine serum containing
SF900-II (Gibco) medium.
Large-scale protein expression was performed by infection of
Trichoplusia ni (Hi5) cells in Insect-Xpress medium (Bio-
whitaker) at a cell density of 2.0 × 106 cells/mL with an
infection course of 48 h. Cells were harvested by centrifugation
and lysed with an M-110EH microfluidizer processor at 18000
psi (Microfluidics).
Protein Purification. Detergent Screen for Extraction
of Syt1 from Insect Cell Membranes. The efficiency of
different detergents in extracting Syt1 from insect membranes
was screened by adding 1 wt % (g)/v (mL) of a detergent to 1
mL of membranes and solubilizing them for 4 h at 4 °C.
Samples were spun at 100000 rpm for 30 min. All detergents
were from Anatrace. Sodium dodecyl sulfate−polyacrylamide
gel electrophoresis (SDS−PAGE) (4 to 15%) was performed
on the supernatant, containing detergent-solubilized Syt1, and
Syt1 was detected by Western blotting with an anti-His
antibody. Syt1 was observed in samples solubilized with n-decyl
β-D-maltopyranoside (DDM), FOS-10, FOS-14, n-ocytl β-D-
glucopyranoside (OG), and HEGA-10. Syt1 was not observed
in samples solubilized with CHAPS, CHAPSO, CYGLU-3, and
LDAO. For further purification, after membrane purification,
Syt1 was extracted from membranes with either FOS-14 or
DDM.
Purification. After membrane purification and detergent
extraction, Syt1 was subsequently “batch” purified with Ni-
NTA resin (Qiagen) at 4 °C, followed by 1D4 antibody affinity
purification, in 20 mM Tris (pH 8.0), 0.5 M NaCl, 10 mM
CaCl2, 5% glycerol, 1% FOS-14 (or DDM), and protease
inhibitors. In general, although the purity after 1D4 affinity
purification was higher, the yield was lower, so we frequently
skipped this step. From the NiNTA resin, the protein was
eluted with 300 mM imidazole (pH 7.5), 500 mM NaCl, and
0.02% DDM, and from the 1D4 antibody column using the
1D4 peptide. Syt1 was further purified by ion exchange
chromatography [MonoS resin (GE Healthcare)] and/or size
exclusion chromatography [KW-803.5 (Shodex)] to remove
the Syt1 fragment of residues 111−421 from the full-length
protein. For ion exchange, Syt1 was loaded in 0.1 M NaCl, 25
mM MES (pH 6.0), 0.02% DDM, and 2 mM β-
mercaptoethanol. Size exclusion chromatography was con-
ducted in 50 mM sodium phosphate (pH 8.0), 150 mM NaCl,
and 0.02% DDM with or without 2 mM β-mercaptoethanol.
For experiments other than lipid-overlay assay tags were
removed using PreScission Protease (GE Healthcare) in size
exclusion chromatography buffer.
Dye Labeling. The mutant full-length Syt1 (1−421,
Cys74Ser, Cys75Ser, Cys77Ser, Cys79Ser, Cys82Ser, Cy-
s277Ser, Gln154Cys) fragment was purified in the same way
as the wild-type protein, and the purified sample was mixed
with Cy5-maleimide (GE Healthcare) in 50 mM sodium
phosphate (pH 8.0), 150 mM NaCl, 0.5 mM TCEP, and 0.02%
DDM and incubated overnight at 4 °C. Free dye was separated
from labeled protein using ion exchange (MonoS). The
presence of Cy5 dye on Gln154Cys was confirmed by mass
spectrometry. The labeling efficiency, estimated by ultraviolet−
visible (UV−vis) dye and protein absorption at respective
wavelengths, was ∼55−80%.
Syt1-C2AB and Syt3-C2AB Expression and Purification. R.
norvegicus Syt1(96−421), Syt3(292−587), Syt1(96−421)
Arg398Glu/Arg399Glu (termed Syt1-C2AB RR), and Syt1-
C2AB(96−421) Lys326Glu/Lys327Ala (termed Syt1-C2AB
KK) fragments were tagged with biotin, expressed in E. coli
as GST fusion proteins, and purified as previously described.
15
Syt1(96−421) Arg398Glu/Arg399Glu and Syt1(96−421)
Lys326Glu/Lys327Ala fragments with an N-terminal Avitag
were generated by gene synthesis (Geneart, AG) and subcloned
into the pGEX6P-1 vector (GE Healthcare). The GST tag was
cleaved with PreScission Protease (GE Healthcare) for all
experiments. The absence of DNA contamination
16 of purified
C2AB fragments was confirmed by the lack of UV−vis
absorption at 260 nm.
Circular Dichroism (CD) Analysis. CD data were
collected on an Aviv202-01 spectrometer equipped with a
thermoelectric unit using a 1 mm path-length cell. Protein
samples were at a concentration of 0.2 mg/mL in buffer
containing 20 mM potassium phosphate (pH 7.0), 150 mM
KCl, and 0.02% dodecyl maltoside (DDM). The protein
concentration was determined by absorption at 280 nm.
Wavelength scans were measured from 190 to 270 nm every 1
nm with an averaging time of 1 s.
Lipids. Egg phosphatidylcholine (eggPC), dioleoylphospha-
tidylethanolamine (DOPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE), brain phosphatidylserine (PS),
brain sphingomyelin (SM), 1,2-dioleoyl-sn-glycero-3-phospho-
(1′-myoinositol) (PtdIns), 1,2-dioleoyl-sn-glycero-3-phospho-
(1′-myoinositol-3′-phosphate) (PtdIns3P), brain phosphatidyli-
nositol 4-phosphate (PtdIns4P), 1,2-dioleoyl-sn-glycero-3-
phospho(1′-myoinositol-5′-phosphate) (PtdIns5P), brain phos-
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sn-glycero-3-phospho(1′-myoinositol-3′,5′-bisphosphate)
[PtdIns(3,5)P2], 1,2-dioleoyl-sn-glycero-3-phospho(1′-myoino-
sitol-3′,4′,5′-trisphosphate) [PtdIns(3,4,5)P3], 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B
sulfonyl) (Lissamine Rhodamine PE), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), and 1-stearoyl-2-oleoyl-sn-
glycero-3-phospho-L-serine (SOPS) were purchased from
Avanti Polar Lipids as chloroform or chloroform/methanol/
water solutions. Dihydrocholesterol was from Sigma-Aldrich,
and it was used instead of cholesterol to prevent cholesterol
oxidation.
Reconstitution of Full-Length Syt1 and Binding to
Supported Lipid Bilayers. Liposomes for Syt1 reconstitu-
tion were made from either 100% POPC or an 80:20 POPC/
SOPS mixture. Liposomes used to make supported lipid
bilayers were made from an 80:20 POPC/SOPS mixture.
Liposomes were made by a dry-film method, in which we dried
the chloroform solution of lipids under argon while
continuously manually rotating a round glass tube to make a
thin lipid film. The thin lipid film was further dried overnight
under vacuum. Lipid films were rehydrated in 50 mM Hepes
(pH 7.0) and 150 mM NaCl at room temperature with
intermittent vortexing. An aqueous content dye, 250 mM
calcein, was added during rehydration to lipids used for Syt1
reconstitution. Both calcein and calcein-free liposomes were
frozen and thawed in liquid nitrogen five times and extruded
through a 50 nm pore filter (Avanti Polar Lipids). For
reconstitution of full-length Syt1 into calcein-POPC/SOPS
liposomes, Cy5-labeled Gln154Cys, Cys74Ser, Cys75Ser,
Cys77Ser, Cys79Ser, Cys82Ser, Cys277Ser Syt1 was mixed
with liposomes at protein:lipid ratio of 1:4000 and decyl
maltoside (Anatrace, Inc.) to a lipid ratio of 1:2. The mixture
was incubated for 30 min at 4 °C, followed by 15 min at room
temperature, and passed over a 12 cm × 0.5 cm CL4B resin
(GE Healthcare) column in detergent-free buffer. Fractions
containing proteoliposomes were collected on the basis of the
calcein absorption wavelength (495 nm). Protein-free POPC/
SOPS supported lipid bilayers were formed on quartz slides by
incubation of quartz/glass sample chambers with 7 mg/mL
liposomes for 20−30 min at room temperature. Sample
chambers were constructed from quartz slides and borosilicate
glass coverslips that were cleaned as previously described.
15
The single-molecule/particle images were collected with a
prism-based total internal reflection (TIR) fluorescence
microscope as previously described.
17 An alternating 488 nm/
635 nm laser illumination sequence was used to determine the
location of calcein-liposome and Cy5-Syt1 spots. Collected
images were corrected for background fluorescence and
fluorescent spots localized as previously described.
15 In Figure
2, calcein and Cy5 spots were colocalized and the number of
colocalized spots was counted; 75% of supported lipid bilayer-
bound calcein-liposomes contained Cy5-Syt1.
Lipid Overlay Assay. Membrane Lipid Strips, PIP Strips,
and SphingoStrips (Echelon Biosciences) contained 100 pmol
of a single lipid species spotted on a hydrophobic membrane.
Full-length Syt1(1−421), Syt1-C2AB(96−421), and Syt3-
C2AB(292−587) constructs were incubated with Membrane
Lipid Strips, PIP Strips, and SphingoStrips (Echelon Bio-
sciences) following the manufacturer’s instructions in an
identical buffer containg 50 mM Tris (pH 8.0), 150 mM
NaCl, 0.02% dodecyl maltoside, 1% nonfat milk, and either 0.1
mM EGTA or 0.1 mM EGTA and 1.1 mM CaCl2. Binding of
Syt to lipids was detected in the following manner. Full-length
Syt1 carrying a 1D4 tag was detected with an anti-1D4 antibody
followed by an alkaline phosphatase secondary antibody.
Alkaline phosphatase was detected with the BCIP/NBT
substrate system (Thermo Scientific). Syt1-C2AB(96−421)
and Syt3-C2AB(292−587) carrying a biotin tag were detected
with streptavidin conjugated to fluorophore AlexaFluor647
(Life Technologies). Streptavidin-AlexaFluor647 fluorescence
was imaged using a fluorescence scanner (Typhoon, Amer-
sham). To quantify binding of full-length Syt1, Syt1-C2AB(96−
421), and Syt3-C2AB(292−587) constructs to lipids, the
chromogenic or fluorescence intensity of lipid spots on
Membrane Lipid Strips, PIP Strips, and SphingoStrips was
integrated and background subtracted using UN-SCAN-IT
(Silk Scientific) gel and blot analysis software.
Biosensor Assay. Site specifically biotinylated Syt1-C2AB
and Syt3-C2AB were immobilized on a streptavidin tip, and
Table 1. Lipid Compositions (mole percent) of Liposomes in Figure 5
a
0% PS,
0%
PtdIns
14% PS,
0% PtdIns
2% PS,
0%
PtdIns
0% PS,
2%
PtdIns
0% PS, 2%
PtdIns3P
0% PS, 2%
PtdIns4P
0% PS, 2%
PtdIns5P
0% PS, 2%
PtdIns(4,5)
P2
0% PS, 2%
PtdIns(3,5)
P2
0% PS, 2%
PtdIns(3,4,5)
P3
cholesterol 40 40 40 40 40 40 40 40 40 40
eggPC 29 22 28 28 28 28 28 28 28 28
DOPE 13 9 12 12 12 12 12 12 12 12
POPE 13 9 12 12 12 12 12 12 12 12
SM 5 5 5 5 5 5 5 5 5 5
lissamine
rhodamine
PE
0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
PS 0 14 2 0 0 0 0 0 0 0
PtdIns 0 0 0 2 0 0 0 0 0 0
PtdIns3P 0 0 0 0 2 0 0 0 0 0
PtdIns4P 0 0 0 0 0 2 0 0 0 0
PtdIns5P 0 0 0 0 0 0 2 0 0 0
PtdIns(4,5)P2 0 0 0 0 0 0 0 2 0 0
PtdIns(3,5)P2 0 0 0 0 0 0 0 0 2 0
PtdIns(3,4,5)
P3
0 0 0 0 0 0 0 0 0 2
aLipid abbreviations are defined in Experimental Procedures.
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interferometry. Syt3 immobilized in this configuration was
previously found to be functional as determined by its ability to
bind to the SNARE complex.
15 Because of the high avidity of
the interaction (many Syt1 on the tip with many lipids on the
vesicle), the binding is nearly irreversible, and thus, equilibrium
has not been reached in these measurements. However, because
all interactions are evaluated under identical conditions, such
measurements are informative, and similar caveats apply to
commonly used pull-down experiments. Liposomes used in the
biosensor assay were composed of various phospholipids,
cholesterol, and a single anionic lipid species used as a target
lipid for assaying its interaction with Syt. Compositions of
liposomes in molar ratios are listed in Table 1. The headgroup
composition of phospholipids mimicked the ratio reported for
total brain extracts,
18,19 the exception being that anionic lipids
(PS, PtdIns, and phosphorylated phosphatidylinositols) were
added at twice the concentration reported for total brain extract
and synaptic vesicles because 90−100% of those lipids are
located in the inner leaflet of the plasma membrane and the
outer leaflet of synaptic vesicles. Liposomes were made by a
dry-film method in the following way. All chloroform solutions
of lipids were mixed at the molar ratios mentioned above and
dried under argon as a thin lipid film on the wall of a round
glass tube while the glass tube was continuously manually
rotated. The thin lipid film was further dried overnight under
vacuum. Thin lipid film was then rehydrated in 20 mM Hepes
(pH 7.2), 150 mM KCl, and 0.1 mM EGTA at 40 °C with
occasional vortexing. The liposome solution was then frozen
and thawed five times in liquid nitrogen and extruded through a
50 nm pore filter (Avestin, Inc.). Lissamine rhodamine
absorption was used to determine the concentration of
extruded liposomes. The size of the extruded liposomes was
checked by dynamic light scattering; all mixtures had radii of
approximately 50 nm (data not shown).
An Octet system (ForteBio, Inc.) equipped with streptavidin
SA biosensors (ForteBio, Inc.) was used to study the Syt1-
C2AB− and Syt3-C2AB−lipid interactions in the absence and
presence of Ca2+. N-Terminally biotinylated Syt1-C2AB, Syt1-
C2AB KK, Syt1-C2AB RR, and Syt3-C2AB constructs at 2.5
μg/mL in 20 mM Hepes (pH 7.2), 150 mM KCl, 100 μM
EGTA, and 0.05% Tween 20 were agitated at 1000 rpm and
bound to streptavidin SA biosensors (ForteBio, Inc.) with
typical capture levels of 2.0−2.9 nm between different proteins.
Syt-loaded biosensors were equilibrated in Tween 20-free
buffer. Syt-loaded biosensors were incubated with 5 μM
liposomes in the case of Syt3C2AB and 20 μM liposomes in
the case of Syt1-C2AB, Syt1-C2AB RR, and Syt1-C2AB KK in
20 mM Hepes (pH 7.2), 150 mM KCl, 100 μM EGTA or 100
μM EGTA, and 1.1 mM Ca2+ at 25 °C. To ensure that binding
of liposomes is synaptotagmin specific, 5 μM liposomes were
incubated with streptavidin biosensors to which synaptotagmin
was not attached, and no binding was observed (Figure 5A). As
a control to show that binding of Syt to streptavidin biosensors
is specific and mediated by the N-terminal biotin tag, we
incubated streptavidin biosensors with 5 mM biotin for 2 h at
room temperature prior to the addition of 2.5 μg/mL N-
terminally biotinylated Syt1-C2AB under the conditions
described above. When the streptavidin biosensors are
preblocked with biotin, we observe no binding of N-teminally
biotinylated Syt to biosenors (data not shown).
Detection of Nitrated Tyrosines in Synaptic Vesicle
Proteins. Frozen brains from 3−4-week-old female Sprague-
Dawley rats were obtained from Charles River Laboratories
International. Synaptic vesicles were purified as previously
described,
20 with an exception that the controlled-pore-glass
chromatography step was omitted and the peripheral protein
removal step was followed. The P3 fraction described by Hell et
al.
20 was used for our experiments. The presence of synaptic
vesicles in the P3 fraction was confirmed by enrichment of α-
synaptophysin, and the presence of Syt1 and synaptobrevin as
detected by Western blotting with their respective antibodies
(Synaptic Systems) (data not shown). The diameter of particles
in the P3 fraction was ∼43 ± 9 nm as determined by dynamic
light scattering (Malvern Instruments) (data not shown),
consistent with reported synaptic vesicle size.
20 For detection of
nitrated tyrosines of synaptic vesicle proteins, purified synaptic
vesicles (P3 fraction) were mixed with 10% (w/v) sodium
dodecyl sulfate in 20 mM Hepes (pH 7.2), 100 mM KCl, and
0.1 mM EGTA, incubated at 40 °C for 30 min, boiled, loaded
onto a 4 to 15% SDS−PAGE gel, and blotted on PVDF
membranes. Proteins with nitrated tyrosines were detected with
primary monoclonal anti-nitrotyrosine rabbit IgG (Life
Technologies) and horseradish peroxidase-linked secondary
(Jackson ImmunoResearch Laboratories) antibodies and
detected on the film using enhanced chemiluminescence (GE
Healthcare). For the detection of Syt1, anti-nitrotyrosine
primary and secondary antibodies were stripped using a
Western blot stripping buffer (Thermo Scientific) and blots
were restained with primary monoclonal anti-Syt1 (BD
Transduction Laboratories) and horseradish peroxidase-linked
secondary (Jackson ImmunoResearch Laboratories) antibodies
and detected on the film using enhanced chemiluminescence
(GE Healthcare). Nitrotyrosine bovine serum albumin (Cay-
man Chemicals) was used as a positive control for anti-
nitrotyrosine antibody and antibody stripping, and as a negative
control for the anti-Syt1 antibody. The location of the SDS−
PAGE markers (Rainbow full range, GE Healthcare) on the
film relative to the developed bands was manually marked with
a pen.
Mass Spectrometry. Sample Preparation. The SDS−
PAGE gel band of insect cell-expressed and -purified full-length
Syt1 was Coomassie-stained (Bio-Rad) and destained in 200 μL
of 25 mM ammonium bicarbonate in 50% (v/v) acetonitrile
(ACN) for 15 min, and then 200 μL of 100% ACN was applied
for 15 min at room temperature. Dithiothreitol (DTT) was
added to a final concentration of 10 mM and incubated at 65
°C for 30 min to reduce the disulfide bonds. The reduced
cysteines were then alkylated with the addition of iodoaceta-
mide (IAA) at a final concentration of 20 mM and incubated at
room temperature in the dark for 30 min. The iodoacetamide
was then removed, and washes were performed with 200 μL of
distilled water followed by addition of 100 μL of ACN. Then
ACN was removed, and 50 μL of the 0.01 μg/μL trypsin
solution was added to the diced gel band, allowed to rehydrate
at 4 °C for 30 min, and then incubated at 37 °C overnight. The
tryptic mixtures were acidified with formic acid (FA) to a final
concentration of 1%. Peptides were extracted three times from
the gel plugs using 50% ACN and 1% FA, concentrated with a
SpeedVac to a desired volume (∼18 μL), and subjected to
liquid chromatography−tandem mass spectrometry analysis.
Liquid Chromatography−Tandem Mass Spectrometry
(LC−MS/MS). Nanoflow reverse phase LC−MS/MS was
performed using a capillary HPLC system (Agilent 1200,
Agilent Technologies) coupled with a linear ion trap mass
spectrometer LTQ-FT Ultra Hybrid ion cyclotron resonance
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pray ionization source built in house. Eight microliters of the
tryptic peptides was preconcentrated and desalted onto a
ZORBAX 300SB-C18 trap column [5 μm (inside diameter) × 5
mm, Agilent Technologies] with 5% ACN and 0.1% FA at a
flow rate of 15 μL/min for 5 min. The separation of the tryptic
peptides was performed on a C18 reverse phase column [75 μm
(inside diameter) × 360 μm (outside diameter) × 100 mm
(length)] packed in house with a 4 μm 100 Å pore size C18
reversed phase stationary phase (Synergy, Phenomenex) kept at
a constant 40 °C using a column heater built in house at a flow
rate of 380 nL/min. The mobile phases consisted of 5%
acetonitrile with 0.1% formic acid (A) and 95% acetonitrile
with 0.1% formic acid (B). A 90 min linear gradient from 18 to
35% B was used. Data were acquired using the Xcalibur
(version 2.0.6) software supplied with the instrument. The LC
runs were monitored in positive ion mode by sequentially
recording survey MS scans (m/z 400−2000), in the ICR cell,
while three MS2 were obtained in the ion trap via CID for the
most intense ions.
Database Searching and Protein Identification. MS/MS
spectra were extracted from raw data files and converted into
mgf files using PAVA (University of California, San Francisco,
CA). Mascot version 2.2 (Matrix Science Inc., London, U.K.)
and X!Tandem
21 were used to perform database searches
against the human subset SwissProt database of the extracted
MS/MS data. The peptide tolerance was set at ±10 ppm with
the MS/MS tolerance set at ±0.6 Da. Trypsin specificity was
used allowing for one missed cleavage. The modifications of
Met oxidation, protein N-terminal acetylation, nitrotyrosine,
and peptide N-terminal pyroglutamic acid formation were
allowed for, and Cys carbamidomethylation was set as a fixed
modification. Search results can be viewed in the gpmDB
(http://rat.thegpm.org) using accession code
GPM64500003242.
■ RESULTS
Insect Cell-Expressed Full-Length Synaptotagmin 1.
Full-length Syt1 has been expressed in various mammalian cell
lines for cell-based assays, but not in quantities amenable for
purification and biochemical studies. To obtain the post-
translational modifications found in natively expressed Syt1, we
expressed Syt1 in a eukaryotic expression system using insect
cells. After purification with affinity chromatography (utilizing
His and 1D4 tags), a SDS−PAGE gel showed that insect cell-
expressed Syt1 contains three bands: a full-length construct
with an apparent molecular mass of ∼65 kDa (the sequence-
predicted molecular mass is 47.4 kDa) that constituted the
majority of the protein, a minor degradation product of ∼40
kDa, and a small amount of SDS-resistant dimer (running
slightly above the 105 kDa molecular mass marker) (Figure
1A). N-Terminal sequencing of the 65 and ∼40 kDa SDS−
PAGE bands showed that the former band starts with residue
Val2 while the latter band starts with residue Lys111. Western
blots against the C-terminal tag confirmed that both species
end at residue Lys421 (data not shown). Thus, the degradation
product corresponds to the C2AB fragment. The observation of
these three SDS−PAGE bands (the main product at ∼65 kDa,
a small amount of SDS-resistant dimer, and the C2AB
fragment) is consistent with the SDS−PAGE profile of Syt1
purified from Rattus synaptic vesicles.
1 The C2AB degradation
fragment can be separated from the full-length species using
either ion exchange or size exclusion chromatography (Figure
3D).
Full-Length Syt1 Is Folded. To determine whether insect
cell-expressed and -purified Syt1 is folded, we measured its
circular dichroism spectrum and compared it to that of the
prokaryotically expressed Syt1-C2AB fragment (Figure 1B,C).
The spectrum of the C2AB fragment has a minimum at 218 nm
indicative of a mainly β-sheet rich fold (Figure 1C), as
previously reported.
22 The circular dichroism spectrum of full-
length Syt1 (Figure 1B) is indicative of a folded protein with an
Figure 1. Purity and circular dichroism spectra of insect cell-expressed
and -purified Syt1. (A) Coomassie-stained 4 to 15% SDS−PAGE gel
of affinity-purified, Hi5-expressed, full-length Syt1. (B) Circular
dichroism spectra of full-length Syt1 in the presence and absence of
Ca2+. (C) Circular dichroism spectra of the E. coli-expressed Syt1-
C2AB fragment in the presence and absence of Ca2+.
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nm) compared to that of the C2AB fragment. This increase in
α-helical content is expected as full-length Syt1 contains a
transmembrane α-helix. In addition, the luminal domain of
Syt1, which is highly homologous to that of Syt2, probably
encompasses an additional α-helical segment, as suggested by
the crystal structure of the Syt2−botulinum neurotoxin B
complex.
23 While it is unknown if the luminal segment remains
α-helical in the absence of botulinum neurotoxin B, it is
nevertheless predicted to be α-helical by secondary structure
prediction algorithms.
The E. coli-expressed Syt1-C2AB fragment binds anionic
lipids, phosphatidylserine (PS) and phosphatidylinositol 4,5-
bisphosphate [PtdIns(4,5)P2], by simultaneously coordinating
Ca2+ to Ca2+-binding loops of the C2A and C2B domains and
to PS and PtdIns(4,5)P2.
10,12,14 Thus, to further confirm that
insect cell-expressed Syt1 is functionally folded, we tested its
ability to bind PS-containing lipid membranes in a Ca2+-
dependent manner. We reconstituted full-length Syt1 into
liposomes (here termed Syt1-liposomes) with or without PS
and assayed the Ca2+ dependence of binding of Syt1-liposomes
to PS-containing supported lipid bilayers by single-molecule
fluorescence microscopy (Figure 2). Liposomes were fluo-
rescently labeled by entrapment of the water-soluble dye,
calcein, inside the liposomes, and the number of fluorescent
liposomes bound to the supported lipid bilayer was counted.
To confirm that binding of Syt1-liposomes to the supported
lipid bilayers is mediated by Syt1, we removed the cytoplasmic
domain of Syt1 from the Syt1-liposomes via digestion with the
chymotrypsin protease (Figure 2A, right bar chart). As a further
conformation that binding of Syt1-liposomes to Syt1-free
supported lipid bilayers is mediated by Syt1, we labeled Syt1
with a fluorescent dye at a specific site and counted the number
of optically colocalized Syt1 and liposome particles bound to
supported lipid bilayers (Figure 2B). Thus, binding of
liposomes with and without PS to PS-containing supported
lipid bilayers is dependent on the presence of both Syt1 and
Ca2+.
Identification of Post-Translational Modifications of
Insect Cell-Expressed Mammalian Syt1. Syt1 expressed in
mammalian cell lines or immunoprecipitated from synaptic
vesicles has several post-translational modifications.
1−3,5,7,8,11,20
We have analyzed post-translational modifications of Hi5 insect
cell-expressed Syt1 to evaluate how closely the pattern of post-
translational modifications match the ones reported for
mammalian cells. Although we obtained good coverage of
peptides (70−86% of the Syt1 sequence), we were unable to
observe the transmembrane domain (residues 52−94) that is
predicted to have several palmitoylation sites (Cys74, Cys75,
Cys77, Cys79, and Cys82). Our mass spectrometry analysis
revealed both previously reported and new post-translational
modifications (Figure 3A).
Tyrosine Nitration. We detected nitration in 6 of 11
surface accessible tyrosine residues, three in the C2A domain
(Tyr151, Tyr216, and Tyr229) and three in the C2B domain
(Tyr311, Tyr364, and Tyr380) (Figure 3B). Tyrosine nitration
is a new post-translational modification of Syt1 that has not
been previously reported for any synaptotagmin isoform.
Integration of the peak intensity for the individual Syt1
peptides suggests a stoichiometry for the nitrotyrosine
modifications of 1−10% depending on the site, with the
exception of Tyr151, which appears to be ∼100% modified
because an unmodified form was not identified. The estimated
1−10% modification for the other sites is a lower limit as the
modification is likely to decrease the ionization potential of the
respective peptides. Despite the low level of modification of
individual sites within the protein population, low-level
modifications can have significant signaling and other bioactive
effects on a system.
24−26
To test whether tyrosine nitration is present in vivo, we
purified Rattus synaptic vesicles, performed SDS−PAGE, and
performed Western blotting with an anti-nitrotyrosine anti-
body. Although synaptic vesicles contain many different
proteins,
19 we observed five distinct nitrated tyrosine bands
(Figure 3C) whose identities are unknown. However, the
location of one of these bands is consistent with Syt1 (Figure
3C), suggesting that tyrosine nitration reported here might
occur in vivo. Sequence alignment showed that Tyr151 is
conserved among all Rattus synaptotagmin isoforms, Tyr216 is
conserved in all but Syt3, Syt8, Syt12, and Syt13 isoforms,
Tyr229 is conserved in Syt1−Syt3, Syt5, Syt9 and Syt10,
Tyr311 is conserved in all isoforms apart from Syt12 and Syt13,
Tyr364 is conserved in Syt1−Syt3, Syt5, Syt6, Syt9, and Syt10,
and Tyr380 is present in only Syt1 (Figure 3B). Interestingly,
R. norvegicus Syt1 Tyr311 corresponds to the same residue as
the tyrosine characterized in Drosophila melanogaster’s Syt AD3
mutant (D. melanogaster Tyr364Asn).
27 Mutation of this Syt1
residue, Tyr311Asn, has an effect on both Syt1-mediated Ca2+-
triggered exocytosis
27 and Syt1 endocytosis.
28
Syt1 Tyr364 is a part of the Ca2+-binding region of the C2B
domain and is only partially conserved (Figure 3B). Although
Tyr364 participates in Ca2+ coordination via its backbone
oxygen, it is possible that nitration of its side chain will
influence the conformation of the Ca2+-binding loops.
Sequence comparison of Syt isoforms (Figure 3B) shows that
Syt4, Syt8, Syt11−Syt13, and Syt15 do not have a tyrosine
residue at this position. Interestingly, these same isoforms have
been either shown or predicted not to bind Ca2+ via their Ca2+-
binding loops.
29,30 Furthermore, the same isoforms bind
anionic lipids and the syntaxin−SNAP-25 binary complex in a
Ca2+-independent manner and inhibit SNARE-mediated, Ca2+-
triggered lipid mixing.
30
Phosphorylation. We detected phosphorylation of the
previously reported Thr128 site
8 and of a new Ser30 site
(Figure 3A). Ser30 is the first reported phosphorylation site in
the Syt1 luminal domain. However, we did not observe the
previously characterized phosphorylation sites, Thr125 (de-
tected in vitro after reaction with casein kinase II) and Thr112
(detected in vitro after reaction with Ca2+/calmodulin-depend-
ent protein kinase II and protein kinase C).
7 Phosphorylation
sites Thr112, Thr125, Thr128, and Ser30 are not conserved
among different Rattus synaptotagmin isoforms (Figure 3B)
and thus are likely isoform specific. The lack of detected
phosphorylation of Thr112 and Thr125 is likely due to the lack
of required kinases in insect cells and/or a low fraction of insect
cell-expressed Syt1 phosphorylated at these sites.
Glycosylation. We detected O-glycosylation of Thr26
(Figure 3A), which is a new O-glycosylation site. We did not
detect O-glycosylation at the previously reported sites, Thr15
and Thr16,
3 which is not surprising because O-glycosylation of
Thr15 and Thr16 requires the presence of synaptobrevin.
3
Analogous to the previously reported O-glycosylation sites
Thr15 and Thr16 and N-glycosylation site Asn24, the newly
detected O-glycosylation site Thr26 is not conserved among
Syt isoforms (Figure 3B). Our mass spectrometry data did not
show N-glycosylation of the previously reported Asn24 site that
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cells, and COS-7 cells, with N-glycan complexity varying
between expression sources.
1−3 The presence of some form of
N-glycans on Hi5 insect cell-expressed Syt1 cannot be excluded
because we have not used mass spectrometry methods that
would allow detection of complex N-glycans. To test whether
N-glycosylation is present in Hi5 insect cell-expressed Syt1, we
treated purified Syt1 with PGNase F (Figure 3D). Purified Syt1
shows three bands in the ∼65 kDa region, and only the faint
top band disappears after incubation with PGNase F (Figure
3D), suggesting that a small fraction of Syt1 could be N-
glycosylated. Interestingly, analogous to the observed differ-
ences in N-glycosylation of Syt1 among different mammalian
expression sources,
1−3 the level of N-glycosylation of Syt1 in
insect cells also varies with the expression source: for Sf9 cell
expression, approximately half of Syt1 is N-glycosylated
(compare Figure S6C and Figure S6D of ref 31). Furthermore,
differences in glycosylation pathways between insect and
mammalian cell lines have been previously described.
32
Figure 3. Post-translational modifications of Syt1. (A) Shown is the sequence of Syt1 from R. norvegicus along with Syt1 post-translational
modifications. The transmembrane domain is colored cyan (residues 58−79), the C2A domain yellow (residues 143−264), and the C2B domain
gray (residues 274−377). Cysteine residues are colored orange (Cys74, Cys75, Cys77, Cys79, Cys82, and Cys277). Cysteines predicted to be
palmitoylated are marked with wavy lines (Cys74, Cys75, Cys77, Cys79, and Cys82). Residues reported in the literature as glycosylated are colored
brown (Thr15, Thr16, and Asn24). Residues reported in the literature as phoshorylated (Thr112, Thr127, and Thr128) are colored magenta. Post-
translational modifications identified here by mass spectrometry are marked by black squares: Thr26 (O-glycosylated, colored brown), Ser30 and
Thr128 (phoshorylated, colored magenta), and Tyr151, Tyr216, Tyr229, Tyr311, Tyr364, and Tyr380 (nitrated, colored green). (B) Local sequence
alignments of R. norvegicus synaptotagmin isoforms for residues carrying post-translational modifications identified here by mass spectrometry:
tyrosine nitration, phosphorylation, and O-glycosylation, as indicated on top of the sequences. The post-translationally modified residue numbers
correspond to those of Syt1. (C) Detection of proteins with nitrated tyrosines in synaptic vesicles. Shown is a representative Western blot of rat
synaptic vesicles (SV). A 4 to 15% SDS−PAGE gel was blotted first with primary anti-nitrotyrosine antibody (left) and then with primary anti-
synaptotagmin 1 antibody (right). SDS−PAGE molecular mass markers (shown as ticks in three lanes in each gel) have been marked on both films
with a pen on the basis of the locations of the SDS−PAGE molecular mass markers on the Western blot membrane. Arrows point to the location of
Syt1. Nitrotyrosine BSA (nBSA) was used as a positive and negative control. (D) SDS−PAGE gel (4 to 15%) stained with Commassie dye of insect
cell-expressed and -purified Syt1 treated with PNGaseF or not treated, as indicated. Right and left lanes contained molecular mass markers.
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Expressed Syt1 and E. coli-Expressed Syt1-C2AB and
Syt3-C2AB Fragments. Synaptotagmin isoforms Syt1 and
Syt3 bind anionic lipids, phosphatidylserine (PS) and
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2], in a
Ca2+-dependent manner via the Ca2+-binding loops of the C2
Figure 4. Lipid binding screen using a lipid overlay assay. (A) Schematic of the lipid overlay assay (left). Full-length Syt1 (cyan) is shown bound to a
lipid spot composed of a single lipid species (gray). The right panel shows a representative example of a lipid strip from a lipid overlay assay showing
the lipid binding profile of the biotin-tagged Syt1-C2AB fragment (for full names of lipid acronyms, see below). Each dark spot on the strip
corresponds to a Syt1-C2AB fragment bound to a single lipid species. (B) Lipid binding profile of full-length Syt1 and Syt1-C2AB and Syt3-C2AB
fragments. After incubation with Syt in the presence (gray bars) or absence (striped white bars) of Ca2+, chromogenic or fluorescence intensities of
all spots on Lipid Strips were integrated and corrected for background intensities. The shown intensities are in arbitrary units (AU). The
reproducibility of lipid binding was tested for a subset of lipids: error bars represent standard deviations from means of two or three independent
experiments. Abbreviations: S1P, sphingosine 1-phosphate; SM, sphingomyelin; SPC, sphingosylphosphorylcholine; Sulfatide, 3-sulfogalactosyl
ceramide; Psychosine, galactosylsphingosine; GM1, monosialoganglioside; GD3, disialoganglioside; PtdIns, phosphatidylinositol; PtdIns3P,
phosphatidylinositol 3-phosphate; PtdIns4P, phosphatidylinositol 4-phosphate; PtdIns5P, phosphatidylinositol 5-phosphate; PtdIns(3,4)P2,
phosphatidylinositol 3,4-bisphosphate; PtdIns(3,5)P2, phosphatidylinositol 3,5-bisphosphate; PtdIns(4,5)P2, phosphatidylinositol 4,5-bisphosphate;
PtdIns(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; PS, phosphatidylserine; PA, phosphatidic acid; LPA, lysophosphatidic acid; PC,
phosphatidylcholine; LPC, lysophosphatidylcholine; PE, phosphatidylethanolamine.
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10,12,14 In addition, the Syt1-C2AB fragment binds
PtdIns(4,5)P2 in a Ca2+-independent manner via its lysine rich
region of the C2B domain.
10,33,34 Both PS and PtdIns(4,5)P2
are enriched in the synaptic plasma membrane and are
therefore poised to interact with Syt1 and participate in
synaptic vesicle−plasma membrane interaction and fusion. In
light of reports about the role of Syt1 in synaptic vesicle
35,36
and Syt3 in multivesicular body
37 endocytosis and recycling,
Figure 5. Anionic lipid binding assay using liposomes. (A) Schematic of the experiment and sensograms of liposome binding to bare streptavidin
biosensors in the presence of Ca2+ (left sensogram) and streptavidin biosensors coated with N-terminally biotin-tagged Syt1 in the absence (middle
sensogram) and presence (right sensogram) of Ca2+. We measured interactions between C2AB fragments of Syt3, Syt1, Syt1 Arg398Glu/Arg399Glu
(Syt1-C2AB RR), and Syt1 Lys326Glu/Lys327Ala (Syt1-C2AB KK) with liposomes containing PC, PE, SM, cholesterol, and a single anionic lipid
species {either PS, PtdIns, or various phosphorylated phosphatidylinositols [PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,5)P2, PtdIns(4,5)P2, and
PtdIns(3,4,5)P3] as indicated in the legend} at ratios similar to those observed in synaptic vesicles
18,19 (for the ratios of different lipids in liposomes,
see Experimental Procedures and Table 1). The binding levels for the sensograms are in units of nanometers. Similar sensograms were observed for
the Syt3-C2AB, Syt1-C2AB KK, and Syt1-C2AB RR fragments (not shown). The solid arrow indicates the time of the addition of liposomes. The
dotted arrow indicates the time of the switch to liposome-free buffer. (B−E) Bars represent the mean amount of bound liposomes detected at the
same time point for all lipid mixtures and normalized by the level of N-terminally biotin-tagged Syt1-C2AB, Syt1-C2AB KK, Syt1-C2AB RR, and
Syt3-C2AB fragments, respectively, captured by streptavidin biosensors. The error bars represent standard deviations obtained from two or three
experiments. Comparison of interaction of Syt1-C2AB (B) and Syt3-C2AB (C) with a panel of anionic lipids in the presence and absence of Ca2+.
Comparison of the interaction of Syt1-C2AB and Syt1-C2AB KK and Syt1-C2AB RR mutants with the lipids in the absence (D) and presence (E) of
Ca2+.
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38 we screened for other potential lipid binding
partners of synaptotagmin isoforms Syt1 and Syt3 (Figure 4).
In addition, to determine if the previously uncharacterized full-
length Syt1 binds lipids different from the isolated C2AB
fragment (residues 96−421), we compared lipid binding
profiles of insect cell-expressed full-length Syt1 and E. coli-
expressed Syt1-C2AB and Syt3-C2AB fragments using two
different lipid binding assays, the lipid overlay assay (Figure 4)
and the biosensor assay (Figure 5). Using a lipid overlay assay,
an array of single-lipid species was simultaneously tested for
interaction with a protein of interest (Figure 4A), thus allowing
rapid screening of protein−lipid interaction with a large
number of different classes of lipids. We tested the interaction
of full-length Syt1 and Syt1-C2AB and Syt3-C2AB fragments
with 26 lipids from different lipid classes (sterols, sphingolipids,
and phospholipids) in the presence and absence of Ca2+. Using
a biosensor assay, a protein of interest tethered to an array of
biosensors was simultaneously assayed for its interaction with
an array of liposomes containing a single target lipid species and
lipids found in plasma and synaptic vesicle membranes, that is,
lipids that are the in vivo lipid membrane milieu of Syt (Figure
5A).
The lipid overlay assay showed that, in addition to the
previously reported Ca2+-dependent binding of Syt1 to anionic
lipids PS and PtdIn(4,5)P2, both full-length insect cell-
expressed Syt1 and the E. coli-expressed Syt1-C2AB fragment
bind to PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,5)P2, and
sulfatide in a Ca2+-dependent fashion (Figure 4B). The main
differences in anionic lipid biding between the Syt1-C2AB
fragment and full-length Syt1 are in the Ca2+-dependent
binding of full-length Syt1 to gangliosides (GM1 and GD3) and
PtdIns(3,4,5)P3. Thus, interaction of full-length Syt1 with
GM1, GD3, and PtdIns(3,4,5)P3 lipids might occur through
Syt1’s luminal, transmembrane, and/or membrane proximal
regions, through the linker (residues 69−95), or it might be
due to the post-translational modifications in the C2AB
domain. The amount of Syt1 bound to PtdIns3P, PtdIns4P,
and PtdIns5P in the presence of Ca2+ using the lipid overlay
assay exceeded the amount bound to PS and PtdIns(4,5)P2.
We compared the lipid binding profile of the Syt1-C2AB
fragment with that of Syt3; Syt3's physiological function is yet
unknown, but Syt3 shares many biochemical properties
15,30,39
with Syt1. With the exception of sulfatide, the C2AB fragments
of Syt1 and Syt3 interact with the same lipids, although the
extent of binding differs in several cases (Figure 4B). The Syt3-
C2AB fragment binds both PtdIns3P and PtdIns5P in a Ca2+-
dependent manner, but less well than Syt1.
Because the lipid overlay assay was performed at a single time
point and at a single concentration of lipids, it is uncertain
whether Syt−lipid interactions have reached equilibrium and if
the observed difference in the extent of binding of Syt to
different anions has different affinities or different on or off
rates. In addition, the observed extent of binding of Syt to
various lipids can be due to the spatial arrangement of lipid
charges in this assay, which is likely different than the one in
liposomes composed of multiple lipid species. For the lipid
overlay assay, patches of lipid contain 100% of the lipid species
of interest (Figure 4A), which results in dense packing of lipids
and, consequently, dense packing of lipid charges. This spatial
arrangement of charge is likely different from that in liposomes
composed of multiple lipid species. Liposomes usually contain a
few percent of anionic lipids that, in the absence of liquid−
liquid or liquid−solid phase separation, diffuse in the plane of
the bilayer and mix with other lipids. Consequently, the local
concentration, in the absence of phase separation, of any
individual lipid is typically relatively low, and in the case of
charged lipids, the charges are likely dispersed.
To compare how the lipid binding profile shown in Figure 4
compares to a situation in which anionic charges are dispersed
and present at physiological concentrations in liposomes
containing other lipids, we repeated the lipid binding assay
using liposomes (for a subset of anionic lipids identified in
Figure 4). Anionic lipids, PS, PtdIns, and various phosphory-
lated PtdIns’s at physiologically comparable concentrations
18,19
were mixed with other lipids at ratios and identities
corresponding to the composition of synaptic vesicles
18,19 and
Table 1. The C2AB fragments of Syt1 and Syt3 were tethered
to the biosensors in a site specific manner, and binding of
liposomes to the biosensors in the presence and absence of
Ca2+ was evaluated at a set time point. Syt1 and Syt3-C2AB
domains interact with the same lipids as in the lipid overlay
assay in the presence of Ca2+. The two lipid binding assays
mostly differ in detection of Ca2+-independent interactions,
especially in the case of PtdInsP2s and PtdInsP3 (Figure 5B,C)
where binding to these lipids is prominent when they are
packed less tightly in the context of liposomes.
We tested which previously identified lipid biding regions of
Syt1 [the Ca2+-binding loops, the Lys rich region (residues
324−327) of the C2B domain, or the Arg398 and Arg399
residues of the C2B domain
33,40] are involved in binding to the
lipids used in our screen. We compared PS, PtdIns, PtdInsPs,
PtdInsP2s, and PtdInsP3 binding profiles for the Syt1-C2AB
fragment with the lipid biding profiles of the Syt1-C2AB
Lys326Glu/Lys327Ala and Arg398Glu/Arg399Glu mutants
(Figure 5D,E). In the absence of Ca2+, we detected binding
of wild-type protein and both mutants only to phosphorylated
PtdIns and not PS (Figure 5D). However, in the absence of
Ca2+, the Lys326Glu/Lys327Ala mutant binds phosphorylated
PtdIns's less well than the wild type while the Arg398Glu/
Arg399Glu mutant binds them to the same degree or slightly
better. In the presence of Ca2+, the wild-type protein and both
mutants bind to both PS and phosphorylated PtdIns's with the
exception of PtdIns(3,4,5)P3. Furthermore, both the Lys326-
Glu/Lys327Ala and Arg398Glu/Arg399Glu mutants bind PS,
PtdInsP, and PtdInsP2 as well as the wild type (Figure 5E).
Thus, areas other than the Ca2+-binding loops are involved in
Ca2+-independent binding of Syt1 and the phosphorylated
phosphatidylinositides used in our screen (Figure 5D), while
binding in the presence of Ca2+ to PS and phosphorylated
phosphatidylinositides is predominantly mediated through
Ca2+-binding loops (Figure 5E). Both observations are
consistent with previously reported interactions of the Syt1-
C2AB fragment with PtdIns(4,5)P2.
10,13,34
■ DISCUSSION
We showed that mammalian full-length Syt1 can be expressed
and purified from insect cells and performed an extensive
characterization of the post-translational modifications and lipid
binding properties of the purified protein. We found both
previously described and several new post-translational
modifications and lipid binding partners. Syt1 binds anionic
phospholipids in a Ca2+-dependent manner by coordinating
Ca2+ between its Ca2+-binding loops and anionic phospholipid
headgroups.
40 The two anionic phospholipids with which Syt1
has been previously shown to interact in a Ca2+-dependent
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10,11 are both enriched in the
inner leaflet of the synaptic plasma membrane. Syt1 has also
been reported to interact in a Ca2+-independent manner with
PtdIns(3,4,5)P3,
11 a lipid also enriched in the plasma
membrane.
38
We performed lipid binding assays in two contexts: one in
which single lipid species were tightly packed and the other in
which anionic lipids were dispersed among other lipids. Tight
packing might be similar to a situation in which lipids would be
located in lipid domains within cell membranes, while the latter
lipid arrangement is similar to a situation in which anionic lipids
are spaced far from one another. Interestingly, in both settings,
binding of Syt1 to several phosphorylated phosphatidylinosi-
tides is stronger than binding to PS or PtdIns(4,5)P2.
Phosphatidylinositol (PtdIns) and its phosphorylated deriva-
tives [PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,4)P2, PtdIns-
(3,5)P2, PtdIns(4,5)P2, and PtdIns(3,4,5)P3] comprise ∼10%
of the total cell lipids. Their enrichment in cell organelles is
highly specific and dynamic and is maintained by phosphor-
ylation of inositol at positions −3, −4, and/or −5 by different
classes of PtdIns kinases.
38 PtdIns(4,5)P2 and PtdIns(3,4,5)P3
have been shown to be enriched in the plasma membrane;
PtdIns4P is enriched in the Golgi but can also be found in the
plasma membrane, while PtdIns3P and PtdIns(3,5)P2 are
enriched in early and late endosomes where they play a role in
trafficking of these organelles.
38
Binding of Syt1 to phosphorylated PtdIns enriched in the
plasma membrane [PtdIns4P, PtdIns(3,4)P2, PtdIns(4,5)P2,
and PtdIns(3,4,5)P3] likely reflects Syt1’s role in synaptic
vesicle exocytosis. Binding to non-plasma membrane PtdIns's
[PtdIns3P, PtdIns5P, PtdIns(3,4)P2, and PtdIns(3,5)P2]
reported here may play a role in synapototagmin-mediated
synaptic vesicle recycling. Syt1, in addition to being the primary
Ca2+ sensor for fast synchronous neurotransmitter release, is
also necessary for endocytosis of synaptic vesicles.
35 The role of
synaptotagmin in endocytosis seems to be conserved across
species because it is observed in plants,
41 nematodes,
42
insects,
43 and mammals.
35 The mechanism of Syt1-mediated
endocytosis is poorly understood; it is sensitive to Ca2+
concentration
35 and thought to involve AP2−clathrin inter-
actions
44 and/or AP2-independent interactions involving Syt1’s
C-terminal domain.
28 While PtdIns(4,5)P2 is required for the
formation of the clathrin coat, pinching of the recycled vesicle
from the plasma membrane requires destruction of PtdIns-
(4,5)P2.
45 Thus, it is possible that Syt1’s association with
endosomal phosphorylated PtdIns plays a role in the synaptic
vesicle recycling mechanism.
Syt1 and Syt3 C2 domains share many biochemical
properties with regard to the interaction with SNARE proteins,
PS-containing lipid membranes, SNARE-mediated lipid mixing,
and membrane bending.
15,30,39,46 However, Syt3 is not involved
in fast neurotransmitter release,
47 and its role in neurons is
currently unknown. It is therefore important to expand the
biochemical characterization of the Syt3-C2AB fragment and
detect differences between lipid interactions of Syt1 and Syt3.
Similar to those with Syt1, interactions of the Syt3-C2AB
fragment with phosphorylated PtdIns likely point to its role in
vesicle recycling. As a case in point, Syt3 is the only
synaptotagmin isoform found in T cells where it is localized
to multivesicular bodies and is reported to control recycling of
CXCR4 through multivesicular bodies, thus controlling chemo-
kine-induced T cell migration.
37 Interestingly, we find (Figure
5D,E) that the mode of interaction of the Syt1-C2AB fragment
with phosphorylated PtdIns is conserved: in the absence of
Ca2+, the primary site of interaction is the lysine rich region in
the C2B domain (Lys324−Lys327) with a minor contribution
from Arg398 and Arg399, while in the presence of Ca2+, the
Ca2+-binding loops seem to primarily interact with singly and
doubly phosphorylated PtdIns. Our data are consistent with
previously characterized interaction of Syt1 with PtdIns(4,5)-
P2.
10,13,34
Using a lipid overlay assay, we observed an interaction of full-
length Syt1 but not of the Syt1-C2AB fragment with the
gangliosides used in our screen, GM1 and GD3, suggesting that
either the luminal region, the transmembrane domain, residues
69−95 of the unstructured linker, or post-translational
modifications of the C2AB domain mediate this interaction.
Although direct interaction between Syt1 and gangliosides has
not been previously reported, the Syt1−ganglioside interaction
is physiologically relevant because botulinum neurotoxin B
(BoNT/B) gains entry into cells by binding Syt1 only in the
presence of gangliosides.
48 Although gangliosides might be
interacting with several regions on Syt1, the interaction is likely
mediated via Syt1 luminal and/or transmembrane domains on
the basis of the following. First, the Syt1-BoNT/B binding site
is located on the luminal/transmembrane domain of Syt1, and
gangliosides are necessary for that interaction.
23,48 Second, the
luminal domain of Syt1 faces the same membrane leaflet in
which gangliosides are preferentially located (extracytoplasmic
leaflet of the plasma membrane).
We have also identified an interaction of Syt1 with sulfatides.
Sulfatides are highly enriched in myelin sheets and are not
abundant in other tissues. During myelogenesis in oligoden-
drocytes, Syt7,
49 not Syt1, is a likely Ca2+ sensor during
lysosomal exocytosis and endocytic recycling of the oligoden-
droglial plasma membrane. Our lipid binding assay shows that
Syt1, not Syt3, binds sulfatide in a Ca2+-dependent manner.
Because of the different localization of sulfatides relative to
Syt1, sulfatide binding to Syt1 likely is not physiologically
relevant and reflects charge architecture requirements for Syt1−
anionic lipid binding.
We found that Syt1 can be nitrated at 6 of 11 surface-
exposed tyrosine residues, three in the C2A domain (Tyr151,
Tyr216, and Tyr229) and three in the C2B domain (Tyr311,
Tyr364, and Tyr380), and that Syt might contain nitrated
tyrosines in vivo. Tyrosine nitration has not been previously
reported for any synaptotagmin isoform, while other proteins
involved in synaptic vesicle fusion, syntaxin1A,
50 NSF,
51 and
potentially SNAP25,
50,52,53 but not synaptobrevin 2,
50 have
been found to be S-nitrosylated.
Nitration and nitrosylation play a role in modulation of
synaptic transmission/exocytosis under both normal and
pathological conditions. Nitric oxide (NO) modulates long-
term potentiation (LTP), a mechanism thought to be
responsible for learning and memory formation in the brain,
by acting as a retrograde secondary messenger from the
postsynaptic to presynaptic neuron. Its role is still unclear
because some studies suggest that NO’s presence is required for
the induction of LTP
54,55 while other reports suggest that its
presence reduces the magnitude of LTP.
56 In addition to the
potential role of nitric oxide in LTP, increased levels of protein
nitration and nitrosylation have been observed in brain tissue
from patients with neurodegenerative diseases (Alzheimer's and
Parkinson’s) as well as diabetes. The molecular mechanism by
which synaptic protein nitration and nitrosylation are
connected with LTP and neurodegenerative diseases is
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disrupts its interaction with Munc18, but not with its SNARE
complex partners, SNAP25 and synaptobrevin.
53,57 Treatment
with NO slightly increases the extent of formation of the
SNARE complex both in vitro and in rat hippocampal
synaptosomes,
57 while NSF nitrosylation has an inhibitory
effect on SNARE disassembly and exocytosis.
51
Tyr311 that we found to be nitrated is located close to the
lysine rich region of the C2B domain (residues 324−327) that
has been implicated in interaction with phosphorylated
inositides.
10,13,33,34 In D. melanogaster’s Syt1 (Tyr364Asn in
D. melanogaster), the Tyr311Asn mutation decreases the
amount of exocytosis at Drosophila’s neuromuscular junction.
The decrease in the amount of exocytosis may be caused by
affecting oligomerization of Syt,
58,59 Syt1’s Ca2+ affinity,
60 and/
or the Syt1−syntxin/SNAP-25 interaction.
61 In addition to its
effect on Ca2+-triggered exocytosis and Syt1−syntaxin/SNAP-
25 interaction, the Tyr311Asn mutant partially inhibits Syt1
endocytosis in PC12 cells;
28 thus, nitration of Tyr311 might
have an effect on synaptic vesicle recycling.
The second nitrated residue in C2B, Tyr364, is a part of the
Ca2+-binding motif and is partially conserved among
synaptotagmin isoforms (Figure 3B). Nitration of the Tyr364
side chain could potentially change the conformation of the
Ca2+-binding loop and alter Ca2+ binding. Tyr364 is located
between Asp363 and Asp365, and mutation of these residues
(corresponding to D. melanogaster Asp416Asn and Asp418Asn)
abolished C2B domain-mediated Ca2+ triggering of synchro-
nous synaptic vesicle fusion.
62 Sequence comparison of Syt
isoforms (Figure 3B) shows that the same synaptotagmin
isoforms (Syt4, Syt8, Syt11−Syt13, and Syt15) that do not have
a tyrosine residue at position 364 (that have been either shown
or predicted not to bind Ca2+ via the Ca2+-binding loops
29,30)
bind anionic lipids and the syntaxin/SNAP-25 complex in a
Ca2+-independent manner and inhibit SNARE-mediated lipid
mixing in vitro.
30
The third nitrated C2B residue, Tyr380, is located in the
loop leading to the proposed SNARE interaction helix
63 on the
side of the C2B domain opposite from Ca2+-binding loops, thus
potentially modulating the Syt1−SNARE interaction. Tyrosines
that are nitrated in the C2A domain, Tyr151 and Tyr216, are
clustered together opposite of the Ca2+-binding loops while
Tyr229 is very close to the Ca2+-binding loop, and nitration
could potentially change the conformation of the loop. Tyr229
is adjacent to Asp230 and in the vicinity of Asp232
(corresponding to D. melanogaster Asp282 and Asp284),
mutations of which abolish C2A-mediated Ca2+-triggered
suppression of asynchronous synaptic vesicle fusion.
62 Finally,
the Syt1 tyrosine nitrations reported here could alter its Ca2+-
mediated interactions with anionic lipid and/or SNARE and
other proteins, thus modulating Ca2+-triggered synaptic vesicle
exo- and endocytosis.
Several studies suggest that phosphorylation can modulate
neurotransmitter release,
64−66 although the role of Syt1
phosphorylation at the previously characterized in vitro sites
(Thr112, Thr128, and Thr125) is unknown. Following
stimulation with K+ depolarization or phorbol esters in PC12
cells and in rat synaptosomes, the fraction of Syt1
phosphorylated at Thr112 increased,
7 whereas in chromaffin
cells, mutations of Thr112, Thr125, and Thr128 had no
detectable effect on exocytosis.
67 However, the effect of
phosphorylation on exocytosis may be subtle because only a
small fraction of total Syt1 is phosphorylated in vivo.
7 We have
detected phosphorylation at two sites in Syt1: the previously
reported Thr128 site
8 and the new Ser30 site. The previously
reported Thr112, Thr125, and Thr128 phosphorylation sites
are located in the linker region between transmembrane and
Ca2+-binding C2 domains, while the new Ser30 phosphor-
ylation site is located in the luminal Syt1 domain.
Consequently, the potential physiological role of Syt1
phosphorylation at Ser30 is likely different from that for the
other phosphorylation sites.
The N-terminal luminal domain of Syt1, containing both N-
and O-glycosylation sites, is highly conserved across species,
4
although it is not conserved among different synaptotagmin
isoforms. For Syt1, both O-glycosylation and N-glycosylation
regulate Syt1’s localization to exocytic vesicles.
2,4 The newly
identified O-glycosylation site at Thr26 might be specific for
insect cell expression, so characterization of Syt1 purified from
natural sources will be required.
In summary, we expressed and purified mammalian Syt1 in
insect cells at levels amenable to biochemical studies and
characterized the purified protein in unprecedented detail. We
have shown that mammalian Syt1 expressed and purified in
insect cells is properly folded and carries post-translational
modifications already identified in mammalian cells along with
a new post-translational modification of Syt1, tyrosine nitration,
and new phosphorylation and O-glycosylation sites. In addition,
we have expanded the panel of anionic lipids with which Syt1
and Syt3 interact. We found that interaction of the Syt1-C2AB
fragment with different anionic lipids is conserved and
mediated by the same regions in the C2AB fragment. Ca2+-
independent interactions seem to be primarily mediated via a
lysine rich region in the C2B domain with a minor contribution
from Arg398 and Arg399, while Ca2+-dependent interactions
are primarily mediated via the Ca2+-binding loops. In
conclusion, insect cell-expressed full-length mammalian Syt1
should be a useful tool for further elucidation of the functional
roles of Syt1, its post-translational modifications, and its
interactions with various lipid and protein binding partners in
the synaptic vesicle cycle.
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